• Nina L Jebsen, Jacob Engellau, Katarina Engström, Henrik C Bauer, Odd R Monge, Ludvig P Muren, Geir E Eide, Clement S Trovik, and Oyvind S Bruland.
• Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway. nina.louise.jebsen@helse-bergen.no
• Int. J. Radiat. Oncol. Biol. Phys. 2013 Aug 1; 86 (5): 949-55.

PurposeTo study the impact of dose fractionation of adjuvant radiation therapy (RT) on local recurrence (LR) and the relation of LR to radiation fields.Methods And MaterialsLR rates were analyzed in 462 adult patients with soft tissue sarcoma who underwent surgical excision and adjuvant RT at five Scandinavian sarcoma centers from 1998 to 2009. Medical records were reviewed for dose fractionation parameters and to determine the location of the LR relative to the radiation portals.ResultsFifty-five of 462 patients developed a LR (11.9%). Negative prognostic factors included intralesional surgical margin (hazard ratio [HR]: 7.83, 95% confidence interval [CI]: 3.08-20.0), high malignancy grade (HR: 5.82, 95% CI: 1.31-25.8), age at diagnosis (HR per 10 years: 1.27, 95% CI: 1.03-1.56), and malignant peripheral nerve sheath tumor histological subtype (HR: 6.66, 95% CI: 2.56-17.3). RT dose was tailored to margin status. No correlation between RT dose and LR rate was found in multiple Cox regression analysis. The majority (65%) of LRs occurred within the primary RT volume.ConclusionsNo significant dose-response effect of adjuvant RT was demonstrated. Interestingly, patients given 45-Gy accelerated RT (1.8 Gy twice daily/2.5 weeks) had the best local outcome. A total dose of 50 Gy in 25 fractions seemed adequate following wide margin surgery. The risk of LR was associated with histopathologic subtype, which should be included in the treatment algorithm of adjuvant RT in soft tissue sarcoma.Copyright © 2013 Elsevier Inc. All rights reserved.

31 keywords...

hide…